(Q47194990)

11 January 2018

title

SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children (English)

1 reference

11 January 2018

1 reference

Xinrui Tan

1

1 reference

11 January 2018

Xiaoli Wang

2

1 reference

11 January 2018

Haiping Chu

3

1 reference

11 January 2018

Honghong Liu

4

1 reference

11 January 2018

Xiaoqing Yi

5

1 reference

11 January 2018

Yanfeng Xiao

6

1 reference

11 January 2018

publication date

12 December 2013

1 reference

11 January 2018

published in

Clinical Endocrinology

1 reference

11 January 2018

volume

81

1 reference

11 January 2018

issue

3

1 reference

11 January 2018

page(s)

363-369

1 reference

11 January 2018

1 reference

Childhood obesity, other cardiovascular risk factors, and premature death

21 January 2018

1 reference

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity

21 January 2018

1 reference

Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.

21 January 2018

1 reference

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects

21 January 2018

1 reference

Sfrp5 correlates with insulin resistance and oxidative stress.

21 January 2018

1 reference

Chemerin: at the crossroads of inflammation and obesity

21 January 2018

1 reference

Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals

21 January 2018

1 reference

Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes

21 January 2018

1 reference

Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer

21 January 2018

1 reference

Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis

21 January 2018

1 reference

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

21 January 2018

1 reference

Epigenetic regulation in obesity

21 January 2018

1 reference

Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.

21 January 2018

1 reference

Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response

21 January 2018

1 reference

Gender differences in plasma leptin concentrations.

21 January 2018

1 reference

Contribution of androgens to the gender difference in leptin production in obese children and adolescents

21 January 2018

1 reference

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels

21 January 2018

1 reference

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

21 January 2018

1 reference

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

Wnt/β-catenin signaling and disease

21 January 2018

1 reference

Wnt signaling in cardiovascular physiology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12361

1 reference

11 January 2018

PubMed ID

24330025

1 reference

11 January 2018